Early-Onset Sepsis Surveillance Study
NCT00874367 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 615
Last updated 2017-09-25
Summary
In this observational study, the NICHD Neonatal Research Network (NRN) is conducting surveillance of all infants born at NRN centers to identify all newborns who are diagnosed with early-onset sepsis (EOS) and/or meningitis. The study will: establish current hospital-based rates of EOS among term and preterm infants in the era of intrapartum antibiotic prophylaxis; monitor the organisms associated with EOS and meningitis; compare asymptomatic and symptomatic infants by gestational age and pathogen; and monitor sepsis-associated mortality rates by pathogen group.
Conditions
- Infant, Newborn
- Infant, Low Birth Weight
- Infant, Small for Gestational Age
- Infant, Premature
- Sepsis
- Gram-Negative Bacterial Infections
- Gram-Positive Bacterial Infections
Sponsors & Collaborators
-
Centers for Disease Control and Prevention
collaborator FED -
National Center for Research Resources (NCRR)
collaborator NIH -
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
collaborator NIH -
NICHD Neonatal Research Network
lead NETWORK
Principal Investigators
-
Abbot R. Laptook, MD · Brown University, Women & Infants Hospital of Rhode Island
-
Michele C. Walsh, MD MS · Case Western Reserve University, Rainbow Babies and Children's Hospital
-
Ronald N. Goldberg, MD · Duke University
-
Barbara J. Stoll, MD · Emory University
-
Brenda B. Poindexter, MD MS · Indiana University
-
Abhik Das, PhD · RTI International
-
Krisa P. Van Meurs, MD · Stanford University
-
Ivan D. Frantz III, MD · Tufts Medical Center
-
Kurt Schibler, MD · Children's Hospital Medical Center, Cincinnati
-
Waldemar A. Carlo, MD · University of Alabama at Birmingham
-
Edward F. Bell, MD · University of Iowa
-
Kristi L. Watterberg, MD · University of New Mexico
-
Pablo J. Sanchez, MD · University of Texas, Southwestern Medical Center at Dallas
-
Kathleen A. Kennedy, MD MPH · The University of Texas Health Science Center, Houston
-
Roger G. Faix, MD · University of Utah
-
Seetha Shankaran, MD · Wayne State University
-
Richard A. Ehrenkranz, MD · Yale University
-
Dale L. Phelps, MD · University of Rochester
-
T. Michael O'Shea, MD · Wake Forest University
Eligibility
- Max Age
- 72 Hours
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-02-28
- Primary Completion
- 2009-12-31
- Completion
- 2011-05-31
Countries
- United States
Study Locations
More Related Trials
-
Selective Antibiotics When Symptoms Develop Versus Universal Antibiotics for Preterm Neonates
NCT06377397 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Diagnostic Performance Comparison Between Procalcitonin-based vs. ANAES-based Guidelines
NCT02590198 ·Status: COMPLETED
-
Procalcitonin for Predicting Serious Bacterial Infection in Infants Less Than 3 Months
NCT00800488 ·Status: COMPLETED
-
Integrative Approach to Identify Environmental Risk Factors for CC-17 Group B Streptococcal Neonatal Infection
NCT02471937 ·Status: COMPLETED ·Phase: NA
-
Clinical Outcome of Neonates With GBS Positive Culture-12 Year Retrospective Study
NCT00326313 ·Status: UNKNOWN
-
Host RNA Profiles to Detect Infections in Young Infants
NCT04823026 ·Status: COMPLETED
-
Neonatal Sepsis and GBS Carriage Study
NCT00861055 ·Status: COMPLETED
-
Molecular Culture for the Diagnosis of Neonatal Sepsis
NCT05763680 ·Status: UNKNOWN
-
In Utero Exposure to SARS-CoV-2 (COVID-19) and Cardiovascular and Metabolic Endpoints in Early Life
NCT04921241 ·Status: COMPLETED
-
Clinical Value of Metagenomic Sequencing in Neonatal Sepsis
NCT05416918 ·Status: COMPLETED
-
Selective Use of Antibiotics in Neonates Born to Mothers With Suspected Chorioamnionitis
NCT03576560 ·Status: COMPLETED
-
Streptococcal Infection and Respiratory Distress in Newborns
NCT00612937 ·Status: COMPLETED
-
Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants
NCT00113191 ·Status: COMPLETED ·Phase: NA
-
Genomic Sequencing in Acutely Ill Neonates
NCT02225522 ·Status: COMPLETED ·Phase: NA
-
New Protocol for Febrile Neonate Management
NCT03183531 ·Status: COMPLETED
-
Dynamics of the Microbiome in the Premature Infant
NCT02121938 ·Status: COMPLETED
-
Interest of the Presepsin Assay as a Biomarker of Bacterial Infection, in the Management of Newborns and Infants Under 3 Months of Age Admitted for Fever in Pediatric Emergency Service (Presepsin)
NCT04076345 ·Status: TERMINATED
-
Maternal- Fetal Infection
NCT03371056 ·Status: COMPLETED ·Phase: NA
-
CCA of SGB PCR Versus SGB Culture at 35-38 SA in the Optimization of Intrapartum Antibiotic Prophylaxis
NCT05005169 ·Status: COMPLETED ·Phase: NA
-
Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns
NCT04355234 ·Status: COMPLETED ·Phase: NA
-
A Prospective Cohort Pilot Study of the Clinical and Molecular Epidemiology of Staphylococcus Aureus in Pregnant Women at the Time of Group B Streptococcal Screening in a Large Urban Medical Center in Chicago, IL USA
NCT00532324 ·Status: COMPLETED ·Phase: NA
-
Microbiome, Antibiotics, and Growth Infant Cohort
NCT03001167 ·Status: COMPLETED
-
Neutrophil CD64 for Early Diagnosis of Nosocomial Infection in Preterm Newborns
NCT01951781 ·Status: UNKNOWN ·Phase: NA
-
Early Diagnosis of Candidiasis in Premature Infants
NCT00109525 ·Status: COMPLETED
-
The Relationship Between GBS Screening in Pregnant Women Insured in Maccabi Healthcare Services (MHS) and Early-onset Neonatal Disease in Israel
NCT04222907 ·Status: COMPLETED